Cerezyme launch to market?

When was Cerezyme launched to market?

Cerezyme (imiglucerase) was first approved by the U.S. Food and Drug Administration in 1994 and entered the market thereafter. [1]

How long has Cerezyme been on the market?

Because Cerezyme’s U.S. approval dates to 1994, the product has been commercially available for decades. [1]

What exactly does “launch to market” refer to for Cerezyme?

For drug products, “launch to market” usually means the first regulatory approval in a major market (such as the FDA in the U.S.), followed by commercial distribution. Cerezyme’s key milestone is its 1994 FDA approval. [1]

Are there later versions or competing products after Cerezyme’s launch?

Cerezyme is a modified enzyme therapy used for Gaucher disease; later competitive products and biosimilar-style entrants in some regions are shaped by regulatory pathways, patent/exclusivity status, and additional approvals. (Specific competitor timelines are not provided in the available sources here.) [1]

Sources

[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020249